RLX T24715
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
RLX is a PI3K/Akt/FoxO3a signaling inhibitor in experimental colon cancer.
CAS nr:
4425-23-4
Purity:
98%
Molecular Weight:
214,26
SMILES:
O=C1N2C(CCCCC2)=NC3=C1C=CC=C3
Formula:
C13H14N2O
Pathway:
Target:
